Business Description
Auro Laboratories Ltd
ISIN : INE292C01011
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.63 | |||||
Debt-to-EBITDA | 2.15 | |||||
Interest Coverage | 13.57 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.49 | |||||
Beneish M-Score | -3.34 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.1 | |||||
3-Year EBITDA Growth Rate | 0.5 | |||||
3-Year EPS without NRI Growth Rate | 2.8 | |||||
3-Year Book Growth Rate | 13.7 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 81.6 | |||||
9-Day RSI | 74.69 | |||||
14-Day RSI | 70.75 | |||||
6-1 Month Momentum % | 9.49 | |||||
12-1 Month Momentum % | 69.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.29 | |||||
Quick Ratio | 0.94 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 160.58 | |||||
Days Sales Outstanding | 88.54 | |||||
Days Payable | 118.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -9.81 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.2 | |||||
Operating Margin % | 20.21 | |||||
Net Margin % | 16.25 | |||||
FCF Margin % | -34.9 | |||||
ROE % | 20.77 | |||||
ROA % | 11.56 | |||||
ROIC % | 14.53 | |||||
ROC (Joel Greenblatt) % | 23.11 | |||||
ROCE % | 22.57 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 19.02 | |||||
PE Ratio without NRI | 19.02 | |||||
Shiller PE Ratio | 29.09 | |||||
Price-to-Owner-Earnings | 20.86 | |||||
PEG Ratio | 11.89 | |||||
PS Ratio | 3.09 | |||||
PB Ratio | 3.55 | |||||
Price-to-Tangible-Book | 3.55 | |||||
Price-to-Operating-Cash-Flow | 7.93 | |||||
EV-to-EBIT | 15.68 | |||||
EV-to-EBITDA | 14.29 | |||||
EV-to-Revenue | 3.61 | |||||
EV-to-FCF | -9.43 | |||||
Price-to-Projected-FCF | 4.14 | |||||
Price-to-DCF (Earnings Based) | 0.8 | |||||
Price-to-Median-PS-Value | 3.51 | |||||
Price-to-Graham-Number | 1.74 | |||||
Earnings Yield (Greenblatt) % | 6.37 | |||||
FCF Yield % | -11.28 | |||||
Forward Rate of Return (Yacktman) % | 1.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Auro Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 482.374 | ||
EPS (TTM) (₹) | 12.58 | ||
Beta | 0.89 | ||
Volatility % | 56.17 | ||
14-Day RSI | 70.75 | ||
14-Day ATR (₹) | 13.604623 | ||
20-Day SMA (₹) | 209.76 | ||
12-1 Month Momentum % | 69.43 | ||
52-Week Range (₹) | 105.2 - 307.2 | ||
Shares Outstanding (Mil) | 6.23 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Auro Laboratories Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Auro Laboratories Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Auro Laboratories Ltd Frequently Asked Questions
What is Auro Laboratories Ltd(BOM:530233)'s stock price today?
When is next earnings date of Auro Laboratories Ltd(BOM:530233)?
Does Auro Laboratories Ltd(BOM:530233) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |